SCHEMBL24009147

SCHEMBL24009147

COc1cc2nccc(C)c2cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 3/20 0.44
PDGFRB P09619 2/20 0.44
TRPA1 O75762 1/20 0.43
SRC P12931 2/20 0.43
TGFBR1 P36897 1/20 0.43
FGFR2 P21802 1/20 0.43
EGFR P00533 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PDPK1 O15530 1/20 0.41
GAK O14976 2/20 0.41
BMPR1B O00238 1/20 0.41
EPHB6 O15197 1/20 0.41
RIPK2 O43353 1/20 0.41
ABL1 P00519 1/20 0.41
LCK P06239 1/20 0.41
EPHA1 P21709 1/20 0.41
EPHA8 P29322 1/20 0.41
ACVR1 Q04771 1/20 0.41
MAP2K5 Q13163 1/20 0.41
COQ8A Q8NI60 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25606792 0.93 PDPK1 (0.47) PDGFRAPDGFRBTRPA1SRCTGFBR1
SCHEMBL24837347 0.88 PDGFRA (0.55) PDGFRAPDGFRBFGFR2EGFRKDR
SCHEMBL1496287 0.86 PDGFRB (0.57) PDGFRAPDGFRBSRCTGFBR1FGFR2
SCHEMBL12503594 0.84 PDGFRB (0.47) PDGFRAPDGFRBSRCTGFBR1FGFR2
Methane SCHEMBL24557063 0.83 PDGFRB (0.46) PDGFRAPDGFRBSRCTGFBR1FGFR2
SCHEMBL5233653 0.82 SMN1; SMN2 (0.49) SMN1; SMN2ACVR1
SCHEMBL24008901 0.82 RET (0.44) PDGFRAPDGFRBTRPA1FGFR2EGFR
SCHEMBL6004195 0.82 SRC (0.48) PDGFRAPDGFRBTRPA1SRCFGFR2
SCHEMBL30430404 0.82 RET (0.44) PDGFRAPDGFRBTRPA1FGFR2EGFR
SCHEMBL14540912 0.80 SRC (0.46) PDGFRAPDGFRBSRCTGFBR1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021225969-A1 IMINO SULFANONE INHIBITORS OF ENPP1 VOLASTRA THERAPEUTICS, INC. (US) 2021-11-11 WO disclosed